Glympse Bio is developing a powerful new paradigm in diagnostics designed to enable earlier, noninvasive detection and monitoring of disease. The company’s technology uses proprietary nanoparticles that interrogate the body for certain disease states and then carry the message to the urine for analysis.
- Sangeeta Bhatia, MD, PhD Co-Founder
- Gabe Kwong, PhD Co-Founder
- Caroline Loew, PhD President and CEO
- Eric Huang, PhD Chief Development Officer
- Roopom Banerjee Chief Business Officer
- Veronica Miller Director, CMC